Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome

Objective: Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder with an increased risk for cardiovascular disease (CVD) that is enhanced by obesity. This study sought to determine whether a panel of cardiovascular risk proteins (CVRPs) would be dysregulated in overweight/obese PCOS pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Manjula Nandakumar, Priya Das, Thozhukat Sathyapalan, Alexandra E. Butler, Stephen L. Atkin
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/15/1/4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588989480042496
author Manjula Nandakumar
Priya Das
Thozhukat Sathyapalan
Alexandra E. Butler
Stephen L. Atkin
author_facet Manjula Nandakumar
Priya Das
Thozhukat Sathyapalan
Alexandra E. Butler
Stephen L. Atkin
author_sort Manjula Nandakumar
collection DOAJ
description Objective: Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder with an increased risk for cardiovascular disease (CVD) that is enhanced by obesity. This study sought to determine whether a panel of cardiovascular risk proteins (CVRPs) would be dysregulated in overweight/obese PCOS patients, highlighting potential biomarkers for CVD in PCOS. Methods: In this exploratory cross-sectional study, plasma levels of 54 CVRPs were analyzed in women with PCOS (n = 147) and controls (n = 97). CVRPs were measured using the SOMAscan proteomic platform (version 3.1), with significant proteins identified through linear models, regression analysis, and receiver operating characteristic (ROC) analysis. Analysis on BMI-matched subsets of the cohort were undertaken. Functional enrichment and protein–protein interaction analyses elucidated the pathways involved. Results: Eleven CVRPs were dysregulated in PCOS (whole set, without matching for body mass index (BMI) or insulin resistance (IR)): leptin, Interleukin-1 receptor antagonist protein (IL-1Ra), polymeric immunoglobulin receptor (PIGR), interleukin-18 receptor (IL-18Ra), C-C motif chemokine 3 (MIP-1a), and angiopoietin-1 (ANGPT1) were upregulated whilst advanced glycosylation end product-specific receptor, soluble (sRAGE), bone morphogenetic protein 6 (BMP6); growth/differentiation factor 2 (GDF2), superoxide dismutase [Mn] mitochondrial (MnSOD), and SLAM family member 5 (SLAF5) were downregulated versus the controls. In BMI-matched (overweight/obese, BMI ≥ 26 kg/m<sup>2</sup>) subset analysis, six CVRPs were common to the whole set: ANGPT1 and IL-1Ra were upregulated; and sRAGE, BMP6, GDF2, and Mn-SOD were downregulated. In addition, lymphotactin (XCL1) was upregulated and placenta growth factor (PIGF), alpha-L-iduronidase (IDUA), angiopoietin-1 receptor, and soluble (sTie-2) and macrophage metalloelastase (MMP12) were downregulated. A subset analysis of BMI-matched plus insulin resistance (IR)-matched women revealed only upregulation of tissue factor (TF) and renin in PCOS, potentially serving as biomarkers for cardiovascular risk in overweight/obese women with PCOS. Conclusions: A combination of upregulated obesity-related CVRPs (ANGPT1/IL/1Ra/XCL1) and downregulated cardioprotective proteins (sRAGE/BMP6/Mn-SOD/GDF2) in overweight/obese PCOS women may contribute to the increased risk for CVD. TF and renin upregulation observed in the BMI- and IR-matched limited sample PCOS subgroup indicates their potential risk of CVD.
format Article
id doaj-art-8c8a7c75450a4de2bcb5343b3517212a
institution Kabale University
issn 2218-273X
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-8c8a7c75450a4de2bcb5343b3517212a2025-01-24T13:24:49ZengMDPI AGBiomolecules2218-273X2024-12-01151410.3390/biom15010004Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary SyndromeManjula Nandakumar0Priya Das1Thozhukat Sathyapalan2Alexandra E. Butler3Stephen L. Atkin4Research Department, Royal College of Surgeons of Ireland, Adliya, Busaiteen 15503, BahrainResearch Department, Royal College of Surgeons of Ireland, Adliya, Busaiteen 15503, BahrainAcademic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RU, UKResearch Department, Royal College of Surgeons of Ireland, Adliya, Busaiteen 15503, BahrainResearch Department, Royal College of Surgeons of Ireland, Adliya, Busaiteen 15503, BahrainObjective: Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder with an increased risk for cardiovascular disease (CVD) that is enhanced by obesity. This study sought to determine whether a panel of cardiovascular risk proteins (CVRPs) would be dysregulated in overweight/obese PCOS patients, highlighting potential biomarkers for CVD in PCOS. Methods: In this exploratory cross-sectional study, plasma levels of 54 CVRPs were analyzed in women with PCOS (n = 147) and controls (n = 97). CVRPs were measured using the SOMAscan proteomic platform (version 3.1), with significant proteins identified through linear models, regression analysis, and receiver operating characteristic (ROC) analysis. Analysis on BMI-matched subsets of the cohort were undertaken. Functional enrichment and protein–protein interaction analyses elucidated the pathways involved. Results: Eleven CVRPs were dysregulated in PCOS (whole set, without matching for body mass index (BMI) or insulin resistance (IR)): leptin, Interleukin-1 receptor antagonist protein (IL-1Ra), polymeric immunoglobulin receptor (PIGR), interleukin-18 receptor (IL-18Ra), C-C motif chemokine 3 (MIP-1a), and angiopoietin-1 (ANGPT1) were upregulated whilst advanced glycosylation end product-specific receptor, soluble (sRAGE), bone morphogenetic protein 6 (BMP6); growth/differentiation factor 2 (GDF2), superoxide dismutase [Mn] mitochondrial (MnSOD), and SLAM family member 5 (SLAF5) were downregulated versus the controls. In BMI-matched (overweight/obese, BMI ≥ 26 kg/m<sup>2</sup>) subset analysis, six CVRPs were common to the whole set: ANGPT1 and IL-1Ra were upregulated; and sRAGE, BMP6, GDF2, and Mn-SOD were downregulated. In addition, lymphotactin (XCL1) was upregulated and placenta growth factor (PIGF), alpha-L-iduronidase (IDUA), angiopoietin-1 receptor, and soluble (sTie-2) and macrophage metalloelastase (MMP12) were downregulated. A subset analysis of BMI-matched plus insulin resistance (IR)-matched women revealed only upregulation of tissue factor (TF) and renin in PCOS, potentially serving as biomarkers for cardiovascular risk in overweight/obese women with PCOS. Conclusions: A combination of upregulated obesity-related CVRPs (ANGPT1/IL/1Ra/XCL1) and downregulated cardioprotective proteins (sRAGE/BMP6/Mn-SOD/GDF2) in overweight/obese PCOS women may contribute to the increased risk for CVD. TF and renin upregulation observed in the BMI- and IR-matched limited sample PCOS subgroup indicates their potential risk of CVD.https://www.mdpi.com/2218-273X/15/1/4polycystic ovary syndromePCOScardiovascular riskbiomarkersproteomics
spellingShingle Manjula Nandakumar
Priya Das
Thozhukat Sathyapalan
Alexandra E. Butler
Stephen L. Atkin
Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
Biomolecules
polycystic ovary syndrome
PCOS
cardiovascular risk
biomarkers
proteomics
title Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
title_full Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
title_fullStr Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
title_full_unstemmed Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
title_short Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
title_sort cardiovascular risk biomarkers in women with and without polycystic ovary syndrome
topic polycystic ovary syndrome
PCOS
cardiovascular risk
biomarkers
proteomics
url https://www.mdpi.com/2218-273X/15/1/4
work_keys_str_mv AT manjulanandakumar cardiovascularriskbiomarkersinwomenwithandwithoutpolycysticovarysyndrome
AT priyadas cardiovascularriskbiomarkersinwomenwithandwithoutpolycysticovarysyndrome
AT thozhukatsathyapalan cardiovascularriskbiomarkersinwomenwithandwithoutpolycysticovarysyndrome
AT alexandraebutler cardiovascularriskbiomarkersinwomenwithandwithoutpolycysticovarysyndrome
AT stephenlatkin cardiovascularriskbiomarkersinwomenwithandwithoutpolycysticovarysyndrome